By Elliot Gulliver-Needham Abrdn has been getting bad headline after bad headline in recent weeks. The firm’s stock price down more than 70 per cent since its peak in 2015, and crashed 29 per cent over August last year alone. The bad news for the firm continued this week, as the Financial Times reported that Harris Associates, a high profile shareholder in Abrdn, had sold its position in the company, saying that they had lost faith in its management. David Herro, deputy chair of Harris Associates, said that Abrdn had a “lack [of] strong product with good track record”, while suggesting that th…